ARMK Form 4: Director Credited 29.129 Dividend-Equivalent Shares

Brian M. DelGhiaccio, a director of Aramark (ARMK), reports a small acquisition tied to dividend-equivalent rights.

Rhea-AI Filing Summary

Brian M. DelGhiaccio, a director of Aramark (ARMK), reports a small acquisition tied to dividend-equivalent rights. The reporting person was credited with 29.129 shares as dividend equivalents on deferred stock units that vest on the same schedule as the underlying awards, and the transaction is recorded as an acquisition at no cash cost. After the credit, the reporting person beneficially owns 11,142.312 shares. The reported transaction date is 08/20/2025. The Form 4 shows this filing was submitted by an attorney-in-fact on behalf of the reporting person.

Insights

Securities Analyst

TL;DR: Routine non-cash acquisition of dividend-equivalent shares by a director; immaterial to company valuation.

This Form 4 records a small acquisition of 29.129 shares credited as dividend equivalents tied to deferred stock units, not a cash purchase or sale. The incremental change against a total beneficial position of 11,142.312 shares is negligible in percentage terms and does not represent a change in control or material shift in insider exposure. For investors, this is a routine equity compensation adjustment rather than a signal of changed insider conviction.

Corporate Governance Expert

TL;DR: Standard director equity compensation mechanics; no governance red flags evident.

The item is explained as dividend-equivalent rights on deferred stock units that vest per existing award schedules. Such credits are common and reflect compensation administration rather than discretionary insider trading. The Form 4 indicates the transaction code and ownership totals clearly, and there is no indication of departures, related-party transactions, or extraordinary governance events in the filing itself.

Insider Trade Summary

Grant/Award: 29.129 shares

Grant/Award 1 txn

Insider DelGhiaccio Brian M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	29.129	$0.00	$0.00

Holdings After Transaction: Common Stock — 11,142.312 shares (Direct)

Footnotes (1)

1. F1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ARMK director Brian M. DelGhiaccio report on Form 4?

The director reported an acquisition of 29.129 shares as dividend-equivalent rights credited on deferred stock units.

Was cash paid for the shares reported on the ARMK Form 4?

No. The transaction is recorded as an acquisition at a $0 price, reflecting dividend-equivalent credits rather than a cash purchase.

How many ARMK shares does the reporting person own after the transaction?

The filing reports beneficial ownership of 11,142.312 shares following the reported transaction.

What is the transaction date shown on the ARMK Form 4?

The reported transaction date is 08/20/2025.

Does this Form 4 indicate a material change in insider holdings or company control?

No. The filing documents a small compensation-related credit and does not indicate a material change in control or significant insider position shift.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/21/2025 - 04:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DelGhiaccio Brian M

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		A		29.129(1)	A	$0	11,142.312	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.